As the biogenesis of EVs might be related to cell activation, we also measured the number of PEVs and found that the numbers of PEVs with CD41 (a specific marker for platelets) positivity and diameters ranging from 100 to 500 nm were much higher in breast cancer patients than in benign patients (Fig. 2D). Here, ITGA2B is linked to breast carcinoma.